Microcirculation and oxidative stress

Free Radical Research

Volumn 41, Issue 12, 2007, Pages 1364-1375

  Crimi, Etorre ^a   Ignarro, L J ^b   Napoli, C ^c,d,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d IRCCS MULTIMEDICA   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Endothelial dysfunction; Microcirculation; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; BETA CAROTENE; C REACTIVE PROTEIN; CATALASE; CYTOKINE; ENDOTHELIN 1; FREE RADICAL; GLUTATHIONE PEROXIDASE; HEMOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; OXYGEN; SCAVENGER; SIMVASTATIN; SUPEROXIDE DISMUTASE;

AGING; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CELL PROLIFERATION; CYTOSKELETON; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION REGULATION; HEMOSTASIS; HUMAN; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; MICROCIRCULATION; MORBIDITY; MORTALITY; NONHUMAN; NUTRIENT CONTENT; OXIDATIVE STRESS; OXYGEN TRANSPORT; PATHOGENESIS; PHYSICAL ACTIVITY; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

AGING; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MICROCIRCULATION; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REPERFUSION INJURY; SEPSIS;

EID: 37349048328     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701732830     Document Type: Article

References (174)

1. Davignon, J. and Ganz, P. (2004) Role of endothelial dysfunction in atherosclerosis. Circulation, 109, pp. IIII27-III32.
2. Suematsu, M., Suzuki, H., DeLano, FA and Schmid-Schonbein, GW. (2002) The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation, 9, pp. 259-276.
3. DeLano, FA, Balete, R. and Schmid-Schonbein, GW. (2005) Control of oxidative stress in microcirculation of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol, 288, pp. H805-H812.
4. Rask-Madsen, C. and King, GL. (2007) Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab, 3, pp. 46-56.
5. Carden, DL and Granger, DN. (2000) Pathophysiology of ischaemia-reperfusion injury. Pathophysiology of ischaemia-reperfusion injury. J Pathol, 190, pp. 255-266.
6. Bateman, RM, Sharpe, MD and Ellis, CG. (2003) Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamics, oxygen transport, and nitric oxide. Crit Care, 7, pp. 359-373.
7. Cooper, D., Stokes, KY, Tailor, A. and Granger, DN. (2002) Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc Toxicol, 2, pp. 165-180.
8. Tritto, I. and Ambrosio, G. (1999) Spotlight on microcirculation: An update. Cardiovasc Res, 42, pp. 600-606.
9. Moncada, S. and Higgs, EA. (2006) The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol, 147, pp. S193-S201.
10. Huang, PL. (2000) Lessons learned from nitric oxide synthase knockout animals. Semin Perinatol, 24, pp. 87-90.
11. Ignarro, LJ, Cirino, G., Casini, A. and Napoli, C. (1999) Nitric oxide as a signaling molecule in the vascular system: An overview. J Cardiovasc Pharmacol, 34, pp. 879-886.
12. Fisher, AB, Chien, S., Barakat, AI and Nerem, RM. (2001) Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol, 281, pp. L529-L533.
13. Ali, MH and Schumacker, PT. (2002) Endothelial responses to mechanical stress: Where is the mechanosensor?. Crit Care Med, 30, pp. S198-S206.
14. Resnick, N., Yahav, H., Schubert, S., Wolfovitz, E. and Shay, A. (2000) Signalling pathways in vascular endothelium activated by shear stress: relevance to atherosclerosis. Curr Opin Lipidol, 11, pp. 167-177.
15. Fisher, AB, Al-Mehdi, AB and Manevich, Y. (2002) Shear stress and endothelial cell activation. Crit Care Med, 30, pp. S192-S197.
16. Chatterjee, S., Levitan, I., Wei, Z. and Fisher, AB. (2006) KATP channels are an important component of the shear-sensing mechanism in the pulmonary microvasculature. Microcirculation, 13, pp. 633-644.
17. Zhou, C. and Wu, S. (2006) T-type calcium channels in pulmonary endothelium. Microcirculation, 13, pp. 645-656.
18. Granger, HJ, Goodman, AH and Cook, BH. (1975) Metabolic models of microcirculatory regulation. Fed Proc, 34, pp. 2025-2030.
19. Vallet, B. (2002) Endothelial cell dysfunction and abnormal tissue perfusion. Crit Care Med, 30, pp. S229-S234.
20. Daut, J., Maier-Rudolph, W., von Beckerath, N., Mehrke, G., Gunther, K. and Goedel-Meinen, L. (1990) Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science, 247, pp. 1341-1344.
21. Moudgil, R., Michelakis, ED and Archer, SL. (2006) The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: Implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension. Microcirculation, 13, pp. 615-632.
22. Waypa, GB and Schumacker, PT. (2005) Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol, 98, pp. 404-414.
23. Napoli, C. and Ignarro, LJ. (2001) Nitric oxide and atherosclerosis. Nitric Oxide, 5, pp. 88-97.
24. Napoli, C., de Nigris, F., Williams-Ignarro, S., Pignalosa, O., Sica, V. and Ignarro, LJ. (2006) Nitric oxide and atherosclerosis: An update. Nitric Oxide, 15, pp. 265-279.
25. Napoli, C., de Nigris, F. and Palinski, W. (2001) Multiple role of reactive oxygen species in the arterial wall. J Cell Biochem, 82, pp. 674-682.
26. Verma, S., Maitland, A., Weisel, RD, Fedak, PW, Pomroy, NC, Li, SH, Mickle, DA, Li, RK and Rao, V. (2002) Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg, 123, pp. 1074-1083.
27. Cai, H. and Harrison, DG. (2000) Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res, 87, pp. 840-844.
28. Collins, DM, McCullough, WT and Ellsworth, ML. (1998) Conducted vascular responses: Communication across the capillary bed. Microvasc Res, 56, pp. 43-53.
29. Turchetti, V., Boschi, L., Donati, G., Trabalzini, L. and Forconi, S. (2006) Impact of hemorheological and endothelial factors on microcirculation. Adv Exp Med Biol, 578, pp. 107-112.
30. Bonetti, PO, Lerman, LO and Lerman, A. (2003) Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol, 23, pp. 168-175.
31. Savoia, C. and Schiffrin, EL. (2007) Vascular inflammation in hypertension and diabetes: Molecular mechanisms and therapeutic interventions. Clin Sci (Lond), 112, pp. 375-384.
32. Ellis, CG, Jagger, J. and Sharpe, M. (2005) The microcirculation as a functional system. Crit Care, 9, pp. S3-S8.
33. Ince, C. (2005) The microcirculation is the motor of sepsis. Crit Care, 9, pp. S13-S19.
34. Zoppo, GJ del and Milner, R. (2006) Integrin-matrix interactions in the cerebral microvasculature. Arterioscler Thromb Vasc Biol, 26, pp. 1966-1975.
35. Anwaruddin, S., Askari, AT and Topol, EJ. (2007) Redefining risk in acute coronary syndromes using molecular medicine. J Am Coll Cardiol, 49, pp. 279-289.
36. Howard-Alpe, GM, Sear, JW and Foex, P. (2006) Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers. Br J Anaesth, 97, pp. 758-769.
37. Ridker, PM, Cannon, CP, Morrow, D., Rifai, N., Rose, LM, McCabe, CH, Pfeffer, MA, Braunwald, E. and Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 352, pp. 20-28.
38. Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Bohm, M. and Nickenig, G. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 353, pp. 999-1007.
39. Baldus, S., Heeschen, C., Meinertz, T., Zeiher, AM, Eiserich, JP, Munzel, T., Simoons, ML, Hamm, CW and CAPTURE investigators (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 108, pp. 1440-1445.
40. Brennan, ML, Penn, MS, Van Lente, F., Nambi, V., Shishehbor, MH, Aviles, RJ, Goormastic, M., Pepoy, ML, McErlean, ES, Topol, EJ, Nissen, SE and Hazen, SL. (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med, 349, pp. 1595-1604.
41. Reinhart, K., Bayer, O., Brunkhorst, F. and Meisner, M. (2002) Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med, 30, pp. S302-S312.
42. Sies, H. (1985) Oxidative stress. Introductory remarks. Oxidative stress, pp. 1-8. Academic Press, London
43. Sies, H. (1986) Biochemistry of oxidative stress. Angew Chem Int Ed, 25, pp. 1058-1071.
44. Sies, H. (2000) What is oxidative stress?. Oxidative stress and vascular diseases, pp. 1-8. Kluwer Academic, Boston, MA
45. Crimi, E., Sica, V., Williams-Ignarro, S., Zhang, H., Slutsky, AS, Ignarro, LJ and Napoli, C. (2006) The role of oxidative stress in adult critical care. Free Radic Biol Med, 40, pp. 398-406.
46. Urbich, C., Dernbach, E., Aicher, A., Zeiher, AM and Dimmeler, S. (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation, 106, pp. 981-986.
47. Terada, LS. (2002) Oxidative stress and endothelial activation. Crit Care Med, 30, pp. S186-S191.
48. Edelman, DA, Jiang, Y., Tyburski, J., Wilson, RF and Steffes, C. (2006) Pericytes and their role in microvasculature homeostasis. J Surg Res, 135, pp. 305-311.
49. Tiruppathi, C., Ahmmed, GU, Vogel, SM and Malik, AB. (2006) Ca2+ signaling, TRP channels, and endothelial permeability. Microcirculation, 13, pp. 693-708.
50. Cioffi, DL and Stevens, T. (2006) Regulation of endothelial cell barrier function by store-operated calcium entry. Microcirculation, 13, pp. 709-723.
51. Townsley, MI, King, JA and Alvarez, DF. (2006) Ca2+ channels and pulmonary endothelial permeability: Insights from study of intact lung and chronic pulmonary hypertension. Microcirculation, 13, pp. 725-739.
52. Minamino, T. and Komuro, I. (2007) Vascular cell senescence: contribution to atherosclerosis. Circ Res, 100, pp. 15-26.
53. Gerhard, M., Roddy, MA, Creager, SJ and Creager, MA. (1996) Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension, 27, pp. 849-853.
54. Payne, GW. (2006) Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation, 13, pp. 343-352.
55. Bearden, SE. (2006) Effect of aging on the structure and function of skeletal muscle microvascular networks. Microcirculation, 13, pp. 279-288.
56. Poole, D., Behnke, B. and Musch, T. (2006) Capillary hemodynamics and oxygen pressures in the aging microcirculation. Microcirculation, 13, pp. 289-299.
57. Wang, JS, Lan, C., Chen, SY and Wong, MK. (2002) Tai Chi Chuan training is associated with enhanced endothelium-dependent dilation in skin vasculature of healthy older men. J Am Geriatr Soc, 50, pp. 1024-1030.
58. Abete, P., Cacciatore, F., Ferrara, N., Calabrese, C., de Santis, D., Testa, G., Galizia, G., Vecchio, S Del, Leosco, D., Condorelli, M., Napoli, C. and Rengo, F. (2003) Body mass index and preinfarction angina in elderly patients with acute myocardial infarction. Am J Clin Nutr, 78, pp. 796-801.
59. Abete, P., Della Morte, D., Mazzella, F., D'Ambrosio, D., Galizia, G., Testa, G., Gargiulo, G., Cacciatore, F. and Rengo, F. (2006) Lifestyle and prevention of cardiovascular disease in the elderly: An Italian perspective. Am J Geriatr Cardiol, 15, pp. 28-34.
60. Faxon, DP, Fuster, V., Libby, P., Beckman, JA, Hiatt, WR, Thompson, RW, Topper, JN, Annex, BH, Rundback, JH, Fabunmi, RP, Robertson, RM, Loscalzo, J. and American heart association (2004) Atherosclerotic vascular disePse conference: Writing group III: pathophysiology. Circulation, 109, pp. 2617-2625.
61. Stokes, KY and Granger, DN. (2005) The microcirculation: A motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?. J Physiol, 562, pp. 647-653.
62. Rodriguez-Porcel, M., Lerman, A., Best, PJ, Krier, JD, Napoli, C. and Lerman, LO. (2001) Hypercholesterolemia impairs myocardial perfusion and permeability: Role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol, 37, pp. 608-615.
63. Tsimikas, S., Brilakis, ES, Miller, ER, McConnell, JP, Lennon, RJ, Kornman, KS, Witztum, JL and Berger, PB. (2005) Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med, 353, pp. 9-11.
64. Steffen, Y., Schewe, T. and Sies, H. (2005) Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun, 331, pp. 1277-1283.
65. Steffen, Y., Jung, T., Klotz, LO, Schewe, T., Grune, T. and Sies, H. (2007) Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: Protection by (-)-epicatechin. Free Radic Biol Med, 42, pp. 955-970.
66. Cooke, JP. (2004) Asymmetrical dimethylarginine: The Uber marker?. Circulation, 109, pp. 1813-1818.
67. Wilson, SH, Caplice, NM, Simari, RD, Holmes Jr, DR, Carlson, PJ and Lerman, A. (2000) Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia. Atherosclerosis, 148, pp. 23-30.
68. Hajra, L., Evans, AI, Chen, M., Hyduk, SJ, Collins, T. and Cybulsky, MI. (2000) The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Natl Acad Sci USA, 97, pp. 9052-9057.
69. Herrmann, J., Best, PJ, Ritman, EL, Holmes, DR, Lerman, LO and Lerman, A. (2002) Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Am Coll Cardiol, 39, pp. 1555-1561.
70. Herrmann, J., Lerman, LO, Mukhopadhyay, D., Napoli, C. and Lerman, A. (2006) Angiogenesis in atherogenesis. Arterioscler Thromb Vasc Biol, 26, pp. 1948-1957.
71. Napoli, C. and Lerman, LO. (2001) Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin Proc, 76, pp. 619-631.
72. de Nigris, F., Lerman, A., Ignarro, LJ, Williams-Ignarro, S., Sica, V., Baker, AH, Lerman, LO, Geng, YJ and Napoli, C. (2003) Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med, 9, pp. 351-359.
73. Tailor, A. and Granger, DN. (2003) Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol, 23, pp. 675-680.
74. Tailor, A. and Granger, DN. (2004) Hypercholesterolemia promotes leukocyte-dependent platelet adhesion in murine postcapillary venules. Microcirculation, 11, pp. 597-603.
75. von Hundelshausen, P. and Weber, C. (2007) Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res, 100, pp. 27-40.
76. Stokes, KY, Clanton, EC, Bowles, KS, Fuseler, JW, Chervenak, D., Chervenak, R., Jennings, SR and Granger, DN. (2002) The role of T-lymphocytes in hypercholesterolemia-induced leukocyte-endothelial interactions. Microcirculation, 9, pp. 407-417.
77. Stokes, KY, Clanton, EC, Clements, KP and Granger, DN. (2003) Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation, 107, pp. 2140-2145.
78. De Kimpe, SJ, Tielemans, W., Van Heuven-Nolsen, D. and Nijkamp, FP. (1994) Reversal of bradykinin-induced relaxation to contraction after interferon-gamma in bovine isolated mesenteric arteries. Eur J Pharmacol, 261, pp. 111-120.
79. Quyyumi, AA, Dakak, N., Diodati, JG, Gilligan, DM, Panza, JA and Cannon, RO 3rd. (1997) Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol, 30, pp. 1220-1227.
80. de Nigris, F., Lerman, LO, Ignarro, SW, Sica, G., Lerman, A., Palinski, W., Ignarro, LJ and Napoli, C. (2003) Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc Natl Acad Sci USA, 100, pp. 1420-1425.
81. de Nigris, F., Williams-Ignarro, S., Lerman, LO, Crimi, E., Botti, C., Mansueto, G., D'Armiento, FP, De Rosa, G., Sica, V., Ignarro, LJ and Napoli, C. (2005) Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc Natl Acad Sci USA, 102, pp. 4896-4901.
82. de Nigris, F., Williams-Ignarro, S., Sica, V., Lerman, LO, D'Armiento, FP, Byrns, RE, Casamassimi, A., Carpentiero, D., Schiano, C., Sumi, D., Fiorito, C., Ignarro, LJ and Napoli, C. (2007) Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis. Cardiovasc Res, 73, pp. 414-423.
83. Heiss, C., Dejam, A., Kleinbongard, P., Schewe, T., Sies, H. and Kelm, M. (2003) Vascular effects of cocoa rich in flavan-3-ols. JAMA, 290, pp. 1030-1031.
84. Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P., Keen, CL, Hollenberg, NK, Sies, H., Kwik-Uribe, C., Schmitz, HH and Kelm, M. (2006) (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA, 103, pp. 1024-1029.
85. Rodriguez-Porcel, M., Lerman, LO, Holmes Jr, DR, Richardson, D., Napoli, C. and Lerman, A. (2002) Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res, 53, pp. 1010-1018.
86. Levine, GN, Frei, B., Koulouris, SN, Gerhard, MD, Keaney Jr, JF and Vita, JA. (1996) Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation, 93, pp. 1107-1113.
87. Anderson, TJ, Elstein, E., Haber, H. and Charbonneau, F. (2000) Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol, 35, pp. 60-66.
88. Wassmann, S., Laufs, U., Muller, K., Konkol, C., Ahlbory, K., Baumer, AT, Linz, W., Bohm, M. and Nickenig, G. (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol, 22, pp. 300-305.
89. Wilson, SH, Simari, RD, Best, PJ, Peterson, TE, Lerman, LO, Aviram, M., Nath, KA, Holmes Jr, DR and Lerman, A. (2001) Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol, 21, pp. 122-128.
90. Wilson, SH, Herrmann, J., Lerman, LO, Holmes Jr, DR, Napoli, C., Ritman, EL and Lerman, A. (2002) Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation, 105, pp. 415-418.
91. Napoli, C., Williams-Ignarro, S., De Nigris, F., Lerman, LO, Rossi, L., Guarino, C., Mansueto, G., Tuoro, F Di, Pignalosa, O., De Rosa, G., Sica, V. and Ignarro, LJ. (2004) Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA, 101, pp. 8797-8802.
92. Napoli, C., Williams-Ignarro, S., de Nigris, F., Lerman, LO, D'Armiento, FP, Crimi, E., Byrns, RE, Casamassimi, A., Lanza, A., Gombos, F., Sica, V. and Ignarro, LJ. (2006) Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice. Proc Natl Acad Sci USA, 103, pp. 10479-10484.
93. Ignarro, LJ, Balestrieri, ML and Napoli, C. (2007) Nutrition, physical activity, and cardiovascular disease: An update. Cardiovasc Res, 73, pp. 326-340.
94. Versari, D., Daghini, E., Rodriguez-Porcel, M., Sattler, K., Galili, O., Pilarczyk, K., Napoli, C., Lerman, LO and Lerman, A. (2006) Chronic antioxidant supplementation impairs coronary endothelial function and myocardial perfusion in normal pigs. Hypertension, 47, pp. 475-481.
95. Chade, AR, Krier, JD, Textor, SC, Lerman, A. and Lerman, LO. (2006) Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia. J Am Soc Nephrol, 17, pp. 3394-3403.
96. Fruchart, JC, Nierman, MC, Stroes, ES, Kastelein, JJ and Duriez, P. (2004) New risk factors for atherosclerosis and patient risk assessment. Circulation, 109, pp. III15-III19.
97. Venugopal, SK, Devaraj, S., Yuhanna, I., Shaul, P. and Jialal, I. (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation, 106, pp. 1439-1441.
98. Verma, S., Li, SH, Badiwala, MV, Weisel, RD, Fedak, PW, Li, RK, Dhillon, B. and Mickle, DA. (2002) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 105, pp. 1890-1896.
99. Wang, CH, Li, SH, Weisel, RD, Fedak, PW, Dumont, AS, Szmitko, P., Li, RK, Mickle, DA and Verma, S. (2003) C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation, 107, pp. 1783-1790.
100. Pasceri, V., Willerson, JT and Yeh, ET. (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102, pp. 2165-2168.
101. Verma, S., Badiwala, MV, Weisel, RD, Li, SH, Wang, CH, Fedak, PW, Li, RK and Mickle, DA. (2003) C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: Implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg, 126, pp. 1886-1891.
102. Napoli, C., Lerman, LO, de Nigris, F., Gossl, M., Balestrieri, ML and Lerman, A. (2006) Rethinking primary prevention of atherosclerosis-related diseases. Circulation, 114, pp. 2517-2527.
103. Pepys, MB, Hirschfield, GM, Tennent, GA, Gallimore, JR, Kahan, MC, Bellotti, V., Hawkins, PN, Myers, RM, Smith, MD, Polara, A., Cobb, AJ, Ley, SV, Aquilina, JA, Robinson, CV, Sharif, I., Gray, GA, Sabin, CA, Jenvey, MC, Kolstoe, SE, Thompson, D. and Wood, SP. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature, 440, pp. 1217-1221.
104. Ridker, PM. (2004) High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefit. Am Heart J, 148, pp. S19-S26.
105. Suzuki, H., Swei, A., Zweifach, BW and Schmid-Schonbein, GW. (1995) In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension, 25, pp. 1083-1089.
106. Swei, A., Lacy, F., Delano, FA, Parks, DA and Schmid-Schonbein, GW. (1999) A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation, 6, pp. 179-187.
107. Lenda, DM, Sauls, BA and Boegehold, MA. (2000) Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol, 279, pp. H7-H14.
108. de Nigris, F., Lerman, LO, Condorelli, M., Lerman, A. and Napoli, C. (2001) Oxidation-sensitive transcription factors and molecular mechanisms in the arterial wall. Antioxid Redox Signal, 3, pp. 1119-1130.
109. Rathaus, M. and Bernheim, J. (2002) Oxygen species in the microvascular environment: Regulation of vascular tone and the development of hypertension. Nephrol Dial Transplant, 17, pp. 216-221.
110. Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T. and Chayama, K. (2002) Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med, 346, pp. 1954-1962.
111. Frisbee, JC, Roman, RJ, Falck, JR, Linderman, JR and Lombard, JH. (2000) Impairment of flow-induced dilation of skeletal muscle arterioles with elevated oxygen in normotensive and hypertensive rats. Microvasc Res, 60, pp. 37-48.
112. Yang, D., Feletou, M., Boulanger, CM, Wu, HF, Levens, N., Zhang, JN and Vanhoutte, PM. (2002) Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol, 136, pp. 104-110.
113. DeLano, FA, Parks, DA, Ruedi, JM, Babior, BM and Schmid-Schonbein, GW. (2006) Microvascular display of xanthine oxidase and NADPH oxidase in the spontaneously hypertensive rat. Microcirculation, 13, pp. 551-566.
114. Wallwork, CJ, Parks, DA and Schmid-Schonbein, GW. (2003) Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res, 66, pp. 30-37.
115. Zhu, XY, Daghini, E., Chade, AR, Rodriguez-Porcel, M., Napoli, C., Lerman, A. and Lerman, LO. (2006) Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arterioscler Thromb Vasc Biol, 26, pp. 1746-1752.
116. Rodriguez-Porcel, M., Zhu, XY, Chade, AR, Amores-Arriaga, B., Caplice, NM, Ritman, EL, Lerman, A. and Lerman, LO. (2006) Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension. Am J Physiol Heart Circ Physiol, 290, pp. H978-H984.
117. Rodriguez-Porcel, M., Lerman, A., Herrmann, J., Schwartz, RS, Sawamura, T., Condorelli, M., Napoli, C. and Lerman, LO. (2003) Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res, 58, pp. 213-221.
118. Rodriguez-Porcel, M., Lerman, LO, Herrmann, J., Sawamura, T., Napoli, C. and Lerman, A. (2003) Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol, 23, pp. 885-891.
119. Rodriguez-Porcel, M., Herrman, J., Chade, AR, Krier, JD, Breen, JF, Lerman, A. and Lerman, LO. (2004) Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension, 43, pp. 493-498.
120. Zhu, XY, Daghini, E., Chade, AR, Napoli, C., Ritman, EL, Lerman, A. and Lerman, LO. (2007) Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol, 18, pp. 1209-1217.
121. Booth, GL, Kapral, MK, Fung, K. and Tu, JV. (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study. Lancet, 368, pp. 29-36.
122. Mäkimattila, S., Virkamäki, A., Groop, PH, Cockcroft, J., Utriainen, T., Fagerudd, J. and Yki-Järvinen, H. (1996) Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation, 94, pp. 1276-1282.
123. Balletshofer, BM, Rittig, K., Enderle, MD, Volk, A., Maerker, E., Jacob, S., Matthaei, S., Rett, K. and Häring, HU. (2000) Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation, 101, pp. 1780-1784.
124. Steinberg, HO, Chaker, H., Leaming, R., Johnson, A., Brechtel, G. and Baron, AD. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest, 97, pp. 2601-2610.
125. De Vriese, AS, Verbeuren, TJ, Van de Voorde, J., Lameire, NH and Vanhoutte, PM. (2000) Endothelial dysfunction in diabetes. Br J Pharmacol, 130, pp. 963-974.
126. Li, H., Gutterman, DD, Rusch, NJ, Bubolz, A. and Liu, Y. (2004) Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes, 53, pp. 2436-2442.
127. Miura, H., Wachtel, RE, Loberiza, FR, Saito, T., Miura, M., Nicolosi, AC and Gutterman, DD. (2003) Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: Reduced activity of ATP-sensitive potassium channels. Circ Res, 92, pp. 151-158.
128. Zeng, G., Nystrom, FH, Ravichandran, LV, Cong, LN, Kirby, M., Mostowski, H. and Quon, MJ. (2000) Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 101, pp. 1539-1545.
129. He, Z., Opland, DM, Way, KJ, Ueki, K., Bodyak, N., Kang, PM, Izumo, S., Kulkarni, RN, Wang, B., Liao, R., Kahn, CR and King, GL. (2006) Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol, 26, pp. 787-793.
130. Nicolls, MR, Haskins, K. and Flores, SC. (2007) Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal, 9, pp. 879-889.
131. Shah, S., Iqbal, M., Karam, J., Salifu, M. and McFarlane, SI. (2007) Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: Pathophysiological insights. Antioxid Redox Signal, 9, pp. 911-929.
132. Liguori, A., Abete, P., Hayden, JM, Cacciatore, F., Rengo, F., Ambrosio, G., Bonaduce, D., Condorelli, M., Reaven, PD and Napoli, C. (2001) Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur Heart J, 22, pp. 2075-2084.
133. Pieper, GM and Siebeneich, W. (1998) Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol, 32, pp. 101-105.
134. Skyrme-Jones, RA, O'Brien, RC, Berry, KL and Meredith, IT. (2000) Vitamin E supplementation improves endothelial function in type I diabetes mellitus: A randomized, placebo-controlled study. J Am Coll Cardiol, 36, pp. 94-102.
135. Ting, HH, Timimi, FK, Boles, KS, Creager, SJ, Ganz, P. and Creager, MA. (1996) Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest, 97, pp. 22-28.
136. de Nigris, F., Balestrieri, ML, Williams-Ignarro, S., D'Armiento, FP, Fiorito, C., Ignarro, LJ and Napoli, C. (2007) The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide, 17, pp. 50-54.
137. Griendling, KK and FitzGerald, GA. (2003) Oxidative stress and carAiovascular injury: Part II: animal and human studies. Circulation, 108, pp. 2034-2040.
138. Mullen, MJ, Wright, D., Donald, AE, Thorne, S., Thomson, H. and Deanfield, JE. (2000) Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: A double-blind study. J Am Coll Cardiol, 36, pp. 410-416.
139. Tsunekawa, T., Hayashi, T., Kano, H., Sumi, D., Matsui-Hirai, H., Thakur, NK, Egashira, K. and Iguchi, A. (2001) Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation, 104, pp. 376-379.
140. Eltzschig, HK and Collard, CD. (2004) Vascular ischaemia and reperfusion injury. Br Med Bull, 70, pp. 71-86.
141. Meredith, IT, Currie, KE, Anderson, TJ, Roddy, MA, Ganz, P. and Creager, MA. (1996) Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol, 270, pp. 1435-14440.
142. Sternbergh, WC, Makhoul, RG and Adelman, B. (1993) Nitric oxide-mediated, endothelium-dependent vasodilation is selectively attenuated in the postischemic extremity. Surgery, 114, pp. 960-967.
143. Davenpeck, KL, Guo, JP and Lefer, AM. (1993) Pulmonary artery endothelial dysfunction following ischemia and reperfusion of the rabbit lung. J Vasc Res, 30, pp. 145-153.
144. Stauton, M., Drexler, C., Dulitz, MG, Ekbom, DC, Schmeling, WT and Farber, NE. (1999) Effects of hypoxia-reoxygenation on microvascular endothelial function in the rat hippocampal slice. Anesthesiology, 91, pp. 1462-1469.
145. Hein, TW, Zhang, C., Wang, W., Chang, CI, Thengchaisri, N. and Kuo, L. (2003) Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: Counteracting role of arginase. FASEB J, 17, pp. 2328-23230.
146. DeFily, DV. (1998) Control of microvascular resistance in physiological conditions and reperfusion. J Mol Cell Cardiol, 30, pp. 2547-2554.
147. Stewart, DJ, Pohl, U. and Bassenge, E. (1988) Free radicals inhibit endothelium-dependent dilation in the coronary resistance bed. Am J Physiol, 255, pp. H765-H769.
148. Tiefenbacher, CP, Chilian, WM, Mitchell, M. and DeFily, DV. (1996) Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation, 94, pp. 1423-1429.
149. Banda, MA, Lefer, DJ and Granger, DN. (1997) Postischemic endothelium-dependent vascular reactivity is preserved in adhesion molecule-deficient mice. Am J Physiol, 273, pp. 2721-2725.
150. Harris, NR and Granger, DN. (1996) Neutrophil enhancement of reperfusion-induced capillary fluid filtration associated with hypercholesterolemia. Am J Physiol, 271, pp. 1755-1761.
151. Harris, NR. (1997) Opposing effects of L-NAME on capillary filtration rate in the presence or absence of neutrophils. Am J Physiol, 273, pp. 1320-1325.
152. Reffelmann, T., Hale, SL, Dow, JS and Kloner, RA. (2003) No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation, 108, pp. 2911-2917.
153. Zimmerman, GA, McIntyre, TM, Prescott, SM and Stafforini, DM. (2002) The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med, 30, pp. S294-S301.
154. Kurose, I., Argenbright, LW, Wolf, R., Lianxi, L. and Granger, DN. (1997) Ischemia/reperfusion-induced microvascular dysfunction: Role of oxidants and lipid mediators. Am J Physiol, 272, pp. 2976-2982.
155. Lehr, HA, Bittinger, F. and Kirkpatrick, CJ. (2000) Microcirculatory dysfunction in sepsis: A pathogenetic basis for therapy?. J Pathol, 190, pp. 373-386.
156. Lam, C., Tyml, K., Martin, C. and Sibbald, W. (1994) Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest, 94, pp. 2077-2083.
157. Piper, RD, Pitt-Hyde, M., Li, F., Sibbald, WJ and Potter, RF. (1996) Microcirculatory changes in rat skeletal muscle in sepsis. Am J Respir Crit Care Med, 154, pp. 931-937.
158. Drazenovic, R., Samsel, RW, Wylam, ME, Doerschuk, CM and Schumacker, PT. (1992) Regulation of perfused capillary density in canine intestinal mucosa during endotoxemia. J Appl Physiol, 72, pp. 259-265.
159. Farquhar, I., Martin, CM, Lam, C., Potter, R., Ellis, CG and Sibbald, WJ. (1996) Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res, 61, pp. 190-196.
160. De Backer, D., Creteur, J., Preiser, JC, Dubois, MJ and Vincent, JL. (2002) Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med, 166, pp. 98-104.
161. Ellis, CG, Jagger, J. and Sharpe, M. (2005) The microcirculation as a functional system. Crit Care, 9, pp. S3-S8.
162. Cerwinka, WH, Cooper, D., Krieglstein, CF, Ross, CR, McCord, JM and Granger, DN. (2003) Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol, 284, pp. H535-H541.
163. Martins, PS, Kallas, EG, Neto, MC, Dalboni, MA, Blecher, S. and Salomao, R. (2003) Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock, 20, pp. 208-212.
164. Bateman, RM, Sharpe, MD and Ellis, CG. (2003) Bench-to-bedside review: microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide. Crit Care, 7, pp. 359-373.
165. Hollenberg, SM, Easington, CR, Osman, J., Broussard, M. and Parrillo, JE. (1999) Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock, 12, pp. 262-267.
166. Kinugawa, K., Takahashi, T., Kohmoto, O., Yao, A., Aoyagi, T., Momomura, S., Hirata, Y. and Serizawa, T. (1994) Nitric oxide-mediated effects of interleuking-6 on [Ca 2 +] and cell contraction in cultured chick ventricular myocytes. Circ Res, 75, pp. 285-295.
167. Kumar, A., Brar, R., Wang, P., Dee, L., Skorupa, G., Khadour, F., Schulz, R. and Parrillo, JE. (1999) Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol, 276, pp. R265-R276.
168. Stein, B., Frank, P., Schmitz, W., Scholz, H. and Thoenes, M. (1996) Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol, 28, pp. 1631-1639.
169. Ullrich, R., Scherrer-Crosbie, M., Bloch, KD, Ichinose, F., Nakajima, H., Picard, MH, Zapol, WM and Quezado, ZM. (2000) Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation, 102, pp. 1440-1446.
170. Strunk, V., Hahnenkamp, K., Schneuing, M., Fischer, LG and Rich, GF. (2001) Selective iNOS inhibition prevents hypothension in septic rats while preserving endothelium-dependent vasodilation. Anesth Analg, 92, pp. 681-682.
171. Revelly, JP, Ayuse, T., Brienza, N., Fessler, HE and Robotham, JL. (1996) Endotoxic shock alters distribution of blood flow within the intestinal wall. Crit Care Med, 24, pp. 1345-1351.
172. Crimi, E., Sica, V., Slutsky, AS, Zhang, H., Williams-Ignarro, S., Ignarro, LJ and Napoli, C. (2006) Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic Res, 40, pp. 665-672.
173. Ichinose, F., Buys, ES, Neilan, TG, Furutani, EM, Morgan, JG, Jassal, DS, Graveline, AR, Searles, RJ, Lim, CC, Kaneki, M., Picard, MH, Scherrer-Crosbie, M., Janssens, S., Liao, R. and Bloch, KD. (2007) Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res, 100, pp. 130-139.
174. Napoli, C., Maione, C., Schiano, C., Fiorito, C. and Ignarro, LJ. (2007) Bone marrow cell-mediated cardiovascular repair: Potential of combined therapies. Trends Mol Med, 13, pp. 278-286.